Key result
This review systematizes literature on the cardiovascular effects of SARS-CoV-2 infection, focusing on electrocardiographic changes in patients with non-coronarogenic syndromes.
Why the study?
As COVID-19 continues to be actively studied, updating and systematizing literature on the cardiovascular effects of SARS-CoV-2 and related surface ECG changes is valuable.
This review systematizes literature on ECG changes and predictors of complications in COVID-19 patients with non-coronarogenic syndromes.
ECG changes warrant attention in non-coronarogenic COVID-19; synthesis leaves open need for prospective validation.
The ongoing pandemic caused by virus SARS-CoV-2 encourages the search for ways to save the population. Since people first encountered this disease, it is being actively studied, and updating medical information is extremely valuable. Since people first encountered this disease, it is being actively studied, and updating medical information is extremely valuable. The purpose of this review is to systematize the literature on the effect of SARS-CoV-2 on the cardiovascular system, focusing on changes in the surface electrocardiogram depending on the clinical course of the disease, the characteristics of the treatment and outcomes, and the possible identification of electrocardiographic predictors of complications, as well as sudden cardiac death in patients with non-coronarogenic syndromes with new virus infection (COVID-19).
No takes yet. Share an insight, caveat, or question.
Shlyakhto et al. (2020) conducted a review in COVID-19 with non-coronarogenic syndromes. SARS-CoV-2 infection was evaluated. This review systematizes literature on the cardiovascular effects of SARS-CoV-2 infection, focusing on electrocardiographic changes in patients with non-coronarogenic syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: